MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Exploring aging-VMAT2 gene-rotenone interactions in a cell model for Parkinson’s disease

H. Jiang, J. Li, C. Han, K. Ma, L. Liu, Y. Shen, L. Wang, S. Guo, Y. Xia, J. Huang, T. Wang (Wuhan, People's Republic of China)

Meeting: 2016 International Congress

Abstract Number: 859

Keywords: Alpha-synuclein, Parkinsonism, Rotenone, Vesicle monamine transporter(VMAT2)

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To develop a Parkinson’s disease (PD) model based on aging, vesicular monoamine transporter 2 (VMAT2) gene susceptibility and chronic rotenone exposure in SK-N-SH cell, in order to better mimic the etiology and pathogenesis of PD.

Background: PD is the second prevailing neurodegenerative disease while the etiology still remains unclear. Though many models have been built to study the pathogenesis of PD, none of them recapitulates the aging-gene-environment interaction pattern, which becomes a conspicuous issue that halts the progression of PD research. Model that could better mimic the etiology and pathogenesis of PD is needed urgently to overcome the bottleneck of PD research. It was indicated that transgenic mice expressing 5% normal VMAT2 levels showed the motor, non-motor symptoms and pathology of α-synuclein accumulation, but only at 28 months old or elder. In this study, we propose to develop a cell model of PD based on ageing, VMAT2 gene susceptibility and chronic rotenone exposure in SK-N-SH cell.

Methods: QRT-PCR was used to evaluate the transfection efficiency. Oxidative stress levels, mitochondrial membrane potentials, aggregations of α-synuclein were compared between different groups with knockdown or overexpression of VMAT2 after rotenone exposure. Results of the qRT-PCR, flow cytometry, and western were analyzed based on SPSS16.0, FlowJo, and Image J respectively.

Results: QRT-PCR and Western blot assays indicated that the levels of VMAT2 mRNA/protein in cultured SK-N-SH cells were significantly reduced to 37.9±17.5% (p<0.01) or raised to 14.83±2.21 (p<0.01) times of control values after VMAT2 shRNA expression plasmids transfection. VMAT2 knockdown enhanced the vulnerability of SK-N-SH cells to the environmental toxin rotenone: obvious cell shrinkage, more accumulation of reactive oxygen species and α-synuclein protein were discovered. Furthermore, though without significant statistical difference, the overexpression group showed a lower oxidative stress level and higher mitochondrial membrane potential than the negative control group, suggesting the protective effect of overexpressing VMAT2 protein in SK-N-SH cells.

Conclusions: In summary, we developed a cell model of PD based on ageing, VMAT2 gene susceptibility and chronic rotenone exposure in SK-N-SH cells, which may better mimic the aging-gene-environment interaction pattern of PD pathogenesis.

To cite this abstract in AMA style:

H. Jiang, J. Li, C. Han, K. Ma, L. Liu, Y. Shen, L. Wang, S. Guo, Y. Xia, J. Huang, T. Wang. Exploring aging-VMAT2 gene-rotenone interactions in a cell model for Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/exploring-aging-vmat2-gene-rotenone-interactions-in-a-cell-model-for-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/exploring-aging-vmat2-gene-rotenone-interactions-in-a-cell-model-for-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley